GE Announces Completion of BioPharma Sale to Danaher, Receives $20 Billion Net Cash Proceeds

/in , /by

BOSTON, Mass.—GE (NYSE:GE) announced today the completion of the sale of its BioPharma business to Danaher Corporation (NYSE:DHR) (“Danaher”) for approximately $20 billion of net proceeds. GE Chairman and CEO H. Lawrence Culp, Jr., said, “Completing the sale of BioPharma represents a critical milestone on our multi-year transformation, fortifying our considerable sources to de-risk our […]

Read more →

Danaher Completes Acquisition Of The Biopharma Business Of General Electric Life Sciences; Business Will Be Called Cytiva

/in , /by

To view this release online and get more information about Danaher Corporation: IR Room visit: https://investors.danaher.com/2020-03-31-Danaher-Completes-Acquisition-Of-The-Biopharma-Business-Of-General-Electric-Life-Sciences-Business-Will-Be-Called-Cytiva WASHINGTON — Danaher Corporation (NYSE: DHR) (“Danaher”) announced today the completion of its acquisition of the Biopharma business from General Electric Company’s (NYSE: GE) Life Sciences division. As part of Danaher, the business will be called Cytiva and will be a […]

Read more →